CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

This small-cap healthcare stock is one of the leaders in the diagnostic space
Vishwesh Sanas
/ Categories: Trending, Mindshare

This small-cap healthcare stock is one of the leaders in the diagnostic space

Shares of the company surged more than 5 per cent today.

Shares of Vijaya Diagnostic Centre Ltd surged 5.6 per cent and closed at Rs 462.1. The stock opened at Rs 438.1 and made an intraday high and low of Rs 483.85 and Rs 437.75, respectively.   

  

Vijaya Diagnostics Centre Limited is among the leading provider of diagnostic medicare services in the southern part of India. It has a stronghold in Telangana and Andhra Pradesh states. According to the June quarterly ending data, the company has a presence in 17 cities and 100 operational centres. 

 

The company’s offerings include health check-ups, radiology, laboratory, nuclear medicine, and medical services. The company's vision is to provide its customers with dependable and accurate diagnostic services at reasonable prices in a customer-centric manner. 

   

As per the FY22 period ending, the company's ROE and ROCE are 26.4 per cent and 28.3 per cent, respectively. For Q1FY23, the company reported a revenue of Rs 104.36 crore. For the same quarter, the company generated a net profit margin of Rs 17.45 crore. 

 

About the shareholding pattern, about 55.01 per cent of the stake is owned by the promoters, 23.89 per cent by FIIs, 15.77 per cent by DIIs, and the rest 5.33 per cent by non-institutional investors.    

 

The company has a market capitalisation of Rs 4716 crore and is trading at a PE multiple of 48.01x. The scrip has a 52-week high and low of Rs 672 and Rs 292, respectively. 

Previous Article Explained: What is activist investing?
Next Article Three of the Murugappa Group stocks turn multibaggers from last Diwali to this one; top-performing stock delivers 121 per cent returns!
Print
4897 Rate this article:
4.3
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR